Mylan Laboratories Limited Voriconazole Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Voriconazole Export Records India — #8 Exporter, 44 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Voriconazole

India Pharmaceutical Trade Intelligence

$31.3M144 Suppliers114 CountriesHS 30049029

ExportsIndia → CHINA20.0%India → UNITED STATES18.6%

ImportsITALY → India$414.7K FRANCE → India$70.5K

#1 Supplier: SANDOZ PRIVATE

Mylan Laboratories Limited — Voriconazole Exporter #8 | $1.4M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Voriconazole Exporter Profile

Indian Pharmaceutical Exporter · #8 for Voriconazole · $1.4M export value · DGFT Verified

Mylan Laboratories Limited is the #8 Indian exporter of Voriconazole with $1.4M in export value and 44 verified shipments. Mylan Laboratories Limited holds a 4.4% market share in Voriconazole exports across 6 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Voriconazole Export Profile: Buyers & Destinations

Mylan Laboratories Limited Voriconazole export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Voriconazole?

Country	Value	Shipments	Share
FRANCE	$426.3K	22	45.5%
UNITED STATES	$197.3K	4	21.1%
NETHERLANDS	$93.6K	9	10.0%
SOUTH AFRICA	$90.8K	3	9.7%
TAIWAN

Who Are the Top Buyers of Voriconazole from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN PHARMACEUTICALS INC	UNITED STATES	$217.7K	5
CSP VIATRIS SANT AT CSP- LAB	FRANCE	$156.4K	6
CSP	FRANCE	$83.2K	4
M/S. CSP MYLAN SAS AT CSP LABO 274	FRANCE	$78.9K	4
CSP MYLAN SAS AT CSP LABO 274	FRANCE	$62.5K	2
VIATRIS ITALIA S.R.L.,	ITALY	$61.0K	2
M/S. MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$56.3K	2
VIATRIS HEALTHCARE PTY LIMITED	SOUTH AFRICA	$50.0K	1
VIATRIS PHARMACEUTICALS CO. LT,	TAIWAN	$35.8K	3
M/S. MYLAN TAIWAN LIMITED	TAIWAN	$32.3K	1

Mylan Laboratories Limited supplies Voriconazole to 18 buyers globally. The largest buyer is MYLAN PHARMACEUTICALS INC (UNITED STATES), followed by CSP VIATRIS SANT AT CSP- LAB (FRANCE) and CSP (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Voriconazole Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
VORICONAZOLE TABLETS 200 MG 30BT TAB (PACKS 30S BOTTLE)(6192 PACKS X 30S=185760 NOS)NOS	$150.0K	3
VORICONAZOLE MYLAN 200 MG 56 BL TAB PACK	$50.0K	1
VORICONAZOLE MYLAN 200 MG 56BL TAB PACKS	$50.0K	1
VORICONAZOLE MYLAN 200 MG 56BL TAB 159	$50.0K	1
VORICONAZOLE MYLAN 200 MG 56BL TAB 2704PACKS X 4 X 14'S = 151424 NOS	$50.0K	1
HARMLESS MEDICINES VORICONAZOLE TAB 200MG 28BL ZA MY	$50.0K	1
VORICONAZOLE TAB 200MG 28BL IT MY (3209 PACKS X 2X14'S = 89852 NOS)	$50.0K	1
HARMLESS MEDICINES VORICONAZOLE MYLAN 200 MG 56BL TAB Voriconazole Tablets 200mg PACK 1 194 000	$50.0K	1
VORICONAZOLE TAB 200MG 56BL PT MY PACKS871	$47.8K	1
VORICONAZOLE TABLETS 50 MG 30BT 4790 PACKS X 30S = 143700 NOS	$47.3K	1

Mylan Laboratories Limited exports 34 distinct Voriconazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VORICONAZOLE TABLETS 200 MG 30BT TAB (PACKS 30S BOTTLE)(6192 with 3 shipments worth $150.0K.

How Does Mylan Laboratories Limited Compare to Nearest Voriconazole Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	ASPIRO PHARMA LIMITED	$1.4M	59	15	$23.8K
7	INTAS PHARMACEUTICALS LIMITED	$1.4M	92	14	$15.2K
8	MYLAN LABORATORIES LIMITED ★	$1.4M	44	6	$31.3K
4	AJANTA PHARMA LIMITED	$1.4M	27	1	$50.0K
5	GLAND PHARMA LTD	$750.0K	15	4	$50.0K

Mylan Laboratories Limited ranks #8 among 144 Indian Voriconazole exporters. Average shipment value of $31.3K compared to the market average of $135.8K. The closest competitors by value are ASPIRO PHARMA LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Voriconazole Exports?

Port	Shipments	% Share
SAHAR AIR	256	18.1%
SAHAR AIR CARGO ACC (INBOM4)	194	13.7%
DELHI AIR CARGO ACC (INDEL4)	112	7.9%
DELHI AIR	103	7.3%
HYDERABAD AIR	68	4.8%
Bombay Air	55	3.9%
HYDERABAD ACC (INHYD4)	49	3.5%
HYDERABAD ICD (INSNF6)	39	2.8%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Voriconazole Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Voriconazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 44 individual customs records matching Mylan Laboratories Limited exporting Voriconazole, covering 34 formulations to 6 countries via 18 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 114+ countries, 393+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Voriconazole

Voriconazole

Mylan Laboratories Limited — Voriconazole Exporter Profile

Mylan Laboratories Limited — Voriconazole Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Voriconazole?

Who Are the Top Buyers of Voriconazole from Mylan Laboratories Limited?

What Is India's Total Voriconazole Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Voriconazole Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Voriconazole Exporters?

What Voriconazole Formulations Does Mylan Laboratories Limited Export?

Regulatory Requirements: Exporting Voriconazole to Key Markets

United States — FDA

How Does Mylan Laboratories Limited Compare to Nearest Voriconazole Exporters?

Which Indian Ports Ship Voriconazole Exports?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Voriconazole Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Voriconazole Export Data from Mylan Laboratories Limited

Voriconazole Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source